Oragenics Inc
0.0 %
-87.17 %
Yet to be announced
Company Overview
Oragenics, Inc. is a biotechnology company focused on the development of novel antibiotics to fight infectious diseases. The company's main focus is on developing products using its lantibiotic program and conducting research in peptide synthesis. The company is still in the research and development phase and does not currently generate revenue from product sales.
Revenue Sources
The company is pre-revenue and in R&D phase, focusing on developing novel antibiotics and therapeutic treatments. Since the company is not generating any revenue yet, this criteria is not applicable at this stage.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
The company is pre-revenue and still in R&D phase. While there is some interest expense ($9,971, $1,803, $7,085, and $0 in the last four quarters), these amounts are minimal relative to total expenses. Given the company's pre-revenue status, the interest expense check is not applicable at this development stage.
Operational Ethics
Based on review of company filings and public information, there is no evidence of any significant ongoing associations with entities involved in human rights violations, including the state of Israel or the Chinese Communist Party.
Login to join the discussion